title: Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
authors.affiliation: Northwestern University Feinberg School of Medicine, Chicago, IL
authors.forename: Kenneth B
authors.initials: KB
authors.lastname: Gordon
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, NY
authors.forename: Jean-Frederic
authors.initials: JF
authors.lastname: Colombel
authors.affiliation: Eli Lilly, Indianapolis, IN
authors.forename: Dana S
authors.initials: DS
authors.lastname: Hardin
mesh_terms: D006801:Humans; D011565:Psoriasis; D012720:Severity of Illness Index; D016896:Treatment Outcome